title: [Sleep apnea-hypopnea syndromes and heart failure].
abstract: Heart failure (HF) and sleep-disordered breathing are conditions highly prevalent in the general population that often co-exist in the same patient. Epidemiological and pathophysiological studies indicate that there may be a causal link between sleep-disordered breathing and HF with either left ventricular systolic dysfunction or preserved ejection fraction. The presence of sleep-disordered breathing in HF patients expose the cardiovascular system to intermittent hypoxia, sympathetic activation, and increased preload and afterload and they trigger several inflammatory, oxidative and neurohumoral mechanisms that may precipitate the progression of the disease. Although there are no available data to indicate that treating sleep-disordered breathing in HF patients reduce cardiac mortality, several studies demonstrate a significant improvement in structural and functional cardiovascular parameters. This review focuses on the clinical and epidemiological bases, the pathophysiological mechanisms and the therapeutic implications between HF and sleep apnea-hypopnea syndromes.
authors.affiliation: Servicio de Cardiología, Complejo Hospitalario de Jaén, Jaén, Spain. maapalomares@secardiologia.es
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Arias
authors.forename: Francisco
authors.initials: F
authors.lastname: García-Río
authors.forename: Alberto
authors.initials: A
authors.lastname: Alonso-Fernández
authors.forename: Ana M
authors.initials: AM
authors.lastname: Sánchez
mesh_terms: D001049:Apnea / Q000150:complications / Q000628:therapy; D002303:Cardiac Output, Low / Q000209:etiology*; D045422:Continuous Positive Airway Pressure; D006333:Heart Failure / Q000209:etiology*; D006801:Humans; D012891:Sleep Apnea Syndromes / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D020182:Sleep Apnea, Central / Q000150:complications / Q000628:therapy; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000628:therapy